Novan (NOVN) – Analyst Ratings
-
Oppenheimer Downgrades Novan (NOVN) to Perform amid Restructuring, Low Cash Levels
-
Novartis shares surge on positive results from key cancer drug trial; a 'best-case scenario'
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to NOVN Stock Lookup